High-dose chemotherapy (HDC) & autologous PBPC transplantation in the adjuvant treatment of high risk breast cancer

被引:0
|
作者
Constenla, M [1 ]
Lorenzo, I [1 ]
Rey, C [1 ]
Carrete, N [1 ]
Campos, B [1 ]
Arroyo, FR [1 ]
Ozores, R [1 ]
机构
[1] Hosp Montecelo, Serv Oncol, Pontevedra, Spain
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
119
引用
收藏
页码:S38 / S38
页数:1
相关论文
共 50 条
  • [1] High-dose chemotherapy & autologous PBPC transplantation in the treatment of inflammatory breast cancer
    Constenla, M
    Lorenzo, I
    Carrete, N
    Rey, C
    Campos, B
    Arroyo, FR
    Ozores, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S38 - S38
  • [2] Taxanes treatment of relapsed breast cancer after high-dose chemotherapy & autologous PBPC transplantation
    Constenla, M
    Lorenzo, I
    Arroyo, FRG
    Rey, C
    Carrete, N
    BONE MARROW TRANSPLANTATION, 1998, 21 : S57 - S57
  • [3] Taxanes treatment of relapsed breast cancer after high-dose chemotherapy & autologous PBPC transplantation
    Constenla, M
    Lorenzo, I
    Campos, B
    Arroyo, FR
    Rey, C
    Carrete, N
    BONE MARROW TRANSPLANTATION, 1999, 23 : S39 - S39
  • [4] High-dose chemotherapy (HDC) with autologous peripheral blood progenitor cell (PBPC) support in patients with metastatic breast cancer
    Constenla, M
    Lorenzo, I
    Carrete, N
    Rey, C
    Campos, B
    Arroyo, FR
    Ozores, R
    Castro, A
    Solla, E
    Villascusa, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S40 - S40
  • [5] High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancer
    Tallman, MS
    Gradishar, WJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (Suppl 1) : S60 - S67
  • [6] High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancer
    Martin S. Tallman
    William J. Gradishar
    Cancer Chemotherapy and Pharmacology, 1998, 42 : S60 - S67
  • [7] Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer
    Tallman, MS
    Gray, R
    Robert, NJ
    LeMaistre, CF
    Osborne, CK
    Vaughan, WP
    Gradishar, WJ
    Pisansky, TM
    Fetting, J
    Paietta, E
    Lazarus, HM
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01): : 17 - 26
  • [8] Taxanes treatment of relapsed breast cancer after high-dose chemotherapy (IQ) & PBPC transplantation
    Constenla, M
    Lorenzo, I
    Arroyo, FRG
    Rey, C
    Carrete, N
    ANNALS OF ONCOLOGY, 1998, 9 : 24 - 24
  • [9] High-dose chemotherapy and autologous haemopoietic stem cell transplantation as adjuvant treatment in high-risk and operable breast cancer: an EBMT retrospective analysis
    Bengala, C.
    Badoglio, M.
    Marco, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S29 - S30
  • [10] High-dose chemotherapy as adjuvant treatment for high-risk primary breast cancer patients
    Bertuzzi, A
    Gullo, G
    Rimassa, L
    Castagna, L
    Santoro, A
    ANNALS OF ONCOLOGY, 2006, 17 (04) : 719 - 720